Top 20 of Glaucoma, Neovascular

Article title # Publications/# Citations

Anti-vascular endothelial growth factor therapy for ocular neovascular disease.

2007: CMAndreoli; JWMiller;

42

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate.

1996: APAdamis; KChatzistefanou; NFerrara; ESGragoudas; JWMiller; MJTolentino;

26

Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease.

2004: EAyuso; ABosch; FBosch; ACarretero; ACasellas; CCosta; MGeorge; VHaurigot; ... CLlombart; VNacher; MNavarro; JRuberte;

23

Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy.

1996: RFolberg; HGnessin; IHemo; AItin; EKeshet; JPe'er;

23

Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection.

2006: FHDavidorf; RJDerick; JGMouser;

22

Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.

2006: DDomig; MEIliev; GMSarra; SWolf; UWolf-Schnurrbursch;

21

Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.

2008: FGomi; YIkuno; MKamei; SKusaka; AMiki; YOshima; YOtori; HSakaguchi; YTano; TWakabayashi;

18

Vascular endothelial growth factor upregulation in human central retinal vein occlusion.

1998: RFolberg; HGnessin; IHemo; AItin; EKeshet; JPe'er;

18

Intravitreal bevacizumab in a patient with neovascular glaucoma.

2006 Mar-Apr: MYKahook; RJNoecker; JSSchuman;

17

Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture.

2001: HDemirci; SGHonavar; CLShields; JAShields;

16

Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma.

2001: JDGass; DMO'Day; JASivak-Callcott; JCTsai;

15

Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone.

2001: JKHayler; JBJonas; SPanda-Jonas; ASöfker;

15

Functional expression of the chemokine receptor CCR7 on fibroblast-like synoviocytes.

2008: HBrühl; DLochbaum; MMack; MNiedermeier; JSchölmerich; RHStraub;

14

Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma.

1998: APAdamis; KVChalam; JLi; BJTripathi; RCTripathi;

14

Intracameral bevacizumab for iris rubeosis.

2006: Tuebingen Bevacizumab Study Group; KUBartz-Schmidt; SBiester; SGrisanti; SPeters; OTatar; FZiemssen;

14

Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease.

2011 Mar-Apr: MTolentino;

14

The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features.

1988: GCBrown; LEMagargal;

14

Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.

2008: JPEhlers; ALam; MASamuel; ASivalingam; MJSpirn; WTasman;

12

Radiation retinopathy after external-beam irradiation: analysis of time-dose factors.

1994: FJBova; CRFitzgerald; WMMendenhall; RRMillion; JTParsons;

12

Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma.

1996: JLHungerford; JEKingston; SAMadreperla; PNPlowman;

12